ЖурналыПодпискаАрхивКнигиПроектыО насРекламаДоставка/ОплатаКонтакты
+7 (495) 482-43-29
  • Главная
  • / Журналы
  • / Вернуться в журнал
  • / Содержание номера
  • / Статья
Современное представление о патофизиологии преэклампсии и ее фенотипах

Современное представление о патофизиологии преэклампсии и ее фенотипах

Авторы:
Елена Сергеевна Ляшко,
Светлана Григорьевна Цахилова,
Рузанна Робертовна Арустамян,
Диана Арамовна Казарян,
Николай Юрьевич Сакварелидзе,
Ирина Вячеславовна Добровольская

Журнал: Проблемы репродукции. 2026;32(5):107-119.

DOI: 10.17116/repro202632051107

Прочитано: 176 раз

Резюме

Преэклампсия — это сложное и многогранное заболевание, которое возникает примерно у 2—5% беременных и остается одной из основных причин материнской и перинатальной заболеваемости и смертности во всем мире. Проявления преэклампсии могут варьировать от легких, почти бессимптомных форм до тяжелых состояний, способных привести к эклампсии или HELLP-синдрому. Несмотря на значительный прогресс в понимании механизмов преэклампсии, она по-прежнему представляет собой сложную задачу для диагностики и лечения. В последние годы ученые активно занимаются исследованием патофизиологии этого заболевания и его фенотипов, разрабатывают комплексные диагностические критерии, ищут новые биомаркеры и создают эффективные стратегии профилактики и мониторинга. Однако, несмотря на все усилия, мнения экспертов и клинические рекомендации по поводу преэклампсии часто расходятся. В этом обзоре обобщены современные мировые представления и имеющиеся разногласия о различных моделях патофизиологии данного состояния. Особое внимание уделяется фенотипам преэклампсии в контексте предложенных моделей.

Ключевые слова

  • преэклампсия
  • фенотипы преэклампсии
  • модели патофизиологии преэклампсии
  • диагностические критерии

Конфликт интересов

Авторы заявляют об отсутствии конфликта интересов.

Дата поступления: 17.03.2026

Дата принятия в печать: 17.07.2026

Дата публикации: 18.11.2026

Литература / References
  1. Kazma JM, van den Anker J, Allegaert K, Dallmann A, Ahmadzia HK. Anatomical and physiological alterations of pregnancy. Journal of Pharmacokinetics and Pharmacodynamics. 2020 Aug;47(4):271-285. https://doi.org/10.1007/s10928-020-09677-1
  2. Cómitre-Mariano B, Martínez-García M, García-Gálvez B, Paternina-Die M, Desco M, Carmona S, Gómez-Gaviro MV. Feto-maternal microchimerism: Memories from pregnancy. iScience. 2021 Dec 29;25(1):103664. https://doi.org/10.1016/j.isci.2021.103664
  3. Martini C, Saeed Z, Simeone P, Palma S, Ricci M, Arata A, Sorella A, Liani R, Ricci F, D’Antonio F, Mattioli AV, Gallina S, Santilli F, Renda G. Preeclampsia: Insights into pathophysiological mechanisms and preventive strategies. American Journal of Preventive Cardiology. 2025 Jul 3;23:101054. https://doi.org/10.1016/j.ajpc.2025.101054
  4. Pereira MM, Torrado J, Sosa C, Zócalo Y, Bia D. Role of arterial impairment in preeclampsia: should the paradigm shift? American Journal of Physiology. Heart and circulatory physiology. 2021,320: H2011-H2030. https://doi.org/10.1152/ajpheart.01005.2020
  5. Bell MJ. A historical overview of preeclampsia-eclampsia. Journal of Obstetric, Gynecologic, and Neonatal Nursing: JOGNN. 2010;39(5):510-518. https://doi.org/10.1111/j.1552-6909.2010.01172.x
  6. Nandagopal P, Sanaullah AAR, Nandagopal S, Wazil SM, Muhammed SA, Sreejith A. Unveiling the risks and outcomes of preeclampsia: a case-control study in the UAE. BMC Pregnancy Childbirth. 2025 Nov 19;25(1):1247. https://doi.org/10.1186/s12884-025-08448-5
  7. Vera-Ponce VJ, Loayza-Castro JA, Ballena-Caicedo J, Valladolid-Sandoval LAM, Zuzunaga-Montoya FE, Gutierrez De Carrillo CI. Global prevalence of preeclampsia, eclampsia, and HELLP syndrome: a systematic review and meta-analysis. Frontiers in Reproductive Health. 2025 Nov 10;7:1706009. https://doi.org/10.3389/frph.2025.1706009
  8. Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, McAuliffe F, da Silva Costa F, von Dadelszen P, McIntyre HD, Kihara AB, Di Renzo GC, Romero R, D’Alton M, Berghella V, Nicolaides KH, Hod M. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. International Journal of Gynaecology and Obstetrics. 2019;145(Suppl. S1):1-33. https://doi.org/10.1002/ijgo.12802
  9. Cresswell JA, Alexander M, Chong MYC, Link HM, Pejchinovska M, Gazeley U, Ahmed SMA, ,Chou D, Moller A-B, Simpson D, Alkema L, Villanueva G, Squassero Ya, Tuncalp Ö, Long Q, Xiao Sh, Say L. Global and regional causes of maternal deaths 2009—20: a WHO systematic analysis. The Lancet Global Health. 2025;13(4):e626-e634. https://doi.org/10.1016/S2214-109X(24)00560-6
  10. Downes KL, Shenassa ED, Grantz KL. Neonatal Outcomes Associated With Placental Abruption. American Journal of Epidemiology. 2017 Dec 15;186(12):1319-1328. https://doi.org/10.1093/aje/kwx202
  11. Zhang L, Yang H, Sun Y, Liu S. Preterm placental abruption and its association with adverse maternal and neonatal outcomes: a retrospective study. BMC Pregnancy Childbirth. 2025 May 28;25(1):620. https://doi.org/10.1186/s12884-025-07718-6
  12. Mooij R, Kapanga RR, Mwampagatwa IH, Mgalega GC, van Dillen J, Stekelenburg J, de Kok BC. Beyond severe acute maternal morbidity: A mixed-methods study on the long-term consequences of (severe pre-) eclampsia in rural Tanzania. Tropical Medicine and International Health. 2021;26(1):33-44. https://doi.org/10.1111/tmi.13507
  13. Davidesko S, Nahum Sacks K, Friger M, Haim A, Sheiner E. Prenatal exposure to preeclampsia as a risk factor for long-term endocrine morbidity of the offspring. Hypertension in Pregnancy. 2021;40(1):21-28. https://doi.org/10.1080/10641955.2020.1854300
  14. Kedar Sade E, Wainstock T, Tsumi E, Sheiner E. Prenatal Exposure to Preeclampsia and Long-Term Ophthalmic Morbidity of the Offspring. Journal of Clinical Medicine. 2020;9(5):1271. https://doi.org/10.3390/jcm9051271
  15. Koulouraki S, Paschos V, Pervanidou P, Christopoulos P, Gerede A, Eleftheriades M. Short- and Long-Term Outcomes of Preeclampsia in Offspring: Review of the Literature. Children (Basel). 2023 May 1;10(5):826. https://doi.org/10.3390/children10050826
  16. Chaiworapongsa T, Chaemsaithong P, Yeo L, Romero R. Pre-eclampsia part 1: current understanding of its pathophysiology. Nature Reviews Nephrology. 2014 Aug;10(8):466-480. https://doi.org/10.1038/nrneph.2014.102
  17. Fox R, Kitt J, Leeson P, Aye CYL, Lewandowski AJ. Preeclampsia: Risk Factors, Diagnosis, Management, and the Cardiovascular Impact on the Offspring. Journal of Clinical Medicine. 2019;8(10):1625. https://doi.org/10.3390/jcm8101625
  18. Nasir M, Asif AB, Waheed M, Irfan J, Khan QU, Waseem A. Exploring Preeclampsia: A Comprehensive Overview. Discoveries (Craiova, Romania). 2025;13(3):e214. https://doi.org/10.15190/d.2025.13
  19. Mitranovici MI, Chiorean DM, Moraru R, Moraru L, Caravia L, Tiron AT, Craina M, Cotoi OS. Understanding the pathophysiology of preeclampsia: Exploring the role of antiphospholipid antibodies and future directions. Journal of Clinical Medicine. 2024;13(9):2668. https://doi.org/10.3390/jcm13092668
  20. James JL, Whitley GS, Cartwright JE. Pre-eclampsia: Fitting together the placental, immune and cardiovascular pieces. Journal of Pathology. 2010;221(4):363-378. https://doi.org/10.1002/path.2719
  21. Twanow JDE, McCabe C, Ream MA. The COVID-19 pandemic and pregnancy: Impact on mothers and newborns. Seminars in Pediatric Neurology. 2022;42:100977. https://doi.org/10.1016/j.spen.2022.100977
  22. Адамян Л.В., Вечорко В.И., Филиппов О.С., Конышева О.В., Ляшко Е.С., Казначеева Т.В., Фаттахова Д.Н., Горбачева Е.Ю. Особенности родовспоможения у беременных с коронавирусной инфекцией. Проблемы репродукции. 2020;26(5):8-16. https://doi.org/10.17116/repro2020260518
  23. Dymara-Konopka W, Laskowska M, Oleszczuk J. Preeclampsia – current management and future approach. Current Pharmaceutical Biotechnology. 2018;19(10):786-796. https://doi.org/10.2174/1389201019666180925120109
  24. Redman CWG, Staff AC, Roberts JM. Syncytiotrophoblast stress in preeclampsia: The convergence point for multiple pathways. American Journal of Obstetrics and Gynecology. 2022;226(2S):S907-S927. https://doi.org/10.1016/j.ajog.2020.09.047
  25. Brosens I, Pijnenborg R, Vercruysse L, Romero R. The «Great Obstetrical Syndromes» are associated with disorders of deep placentation. American Journal of Obstetrics and Gynecology. 2011;204(3):193-201. https://doi.org/10.1016/j.ajog.2010.08.009
  26. Brosens IA, Robertson WB, Dixon HG. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstetrics and Gynecology Annual. 1972;1:177-191.
  27. Redman C. Pre-eclampsia: A complex and variable disease. Pregnancy Hypertension. 2014;4:241-242.
  28. Bakrania BA, Spradley FT, Drummond HA, LaMarca B, Ryan MJ, Granger JP. Preeclampsia: Linking placental ischemia with maternal endothelial and vascular dysfunction. Comprehensive Physiology. 2020;11(1):1315-1349. https://doi.org/10.1002/cphy.c200008
  29. Huppertz B. Maternal-fetal interactions, predictive markers for preeclampsia, and programming. Journal of reproductive immunology. 2015;108:26-32. https://doi.org/10.1016/j.jri.2014.11.003
  30. McElwain CJ, Tuboly E, McCarthy FP, McCarthy CM. Mechanisms of endothelial dysfunction in pre-eclampsia and gestational diabetes mellitus: Windows into future cardiometabolic health? Frontiers in Endocrinology. 2020;11:655. https://doi.org/10.3389/fendo.2020.00655
  31. Dimitriadis E, Rolnik DL, Zhou W, Estrada-Gutierrez G, Koga K, Francisco RPV, Whitehead C, Hyett J, da Silva Costa F, Nicolaides K, Menkhorst E. Pre-eclampsia. Nature Reviews Disease Primers. 2023 Feb 16;9(1):8. https://doi.org/10.1038/s41572-023-00417-6
  32. Torres-Torres J, Espino-Y-Sosa S, Martinez-Portilla R, Borboa-Olivares H, Estrada-Gutierrez G, Acevedo-Gallegos S, Ruiz-Ramirez E, Velasco-Espin M, Cerda-Flores P, Ramirez-Gonzalez A, Rojas-Zepeda L. A Narrative Review on the Pathophysiology of Preeclampsia. International Journal of Molecular Sciences. 2024 Jul 10;25(14):7569. https://doi.org/10.3390/ijms25147569
  33. Magee LA, Brown MA, Hall DR, Gupte S, Hennessy A, Karumanchi SA, Kenny LC, McCarthy F, Myers J, Poon LC, Rana S, Saito S, Staff AC, Tsigas E, von Dadelszen P. The 2021 International Society for the Study of Hypertension in Pregnancy Classification, Diagnosis & Management Recommendations for International Practice. Pregnancy Hypertension. 2022;27:148-169. https://doi.org/10.1016/j.preghy.2021.09.008
  34. NICE Guideline NG133: Hypertension in Pregnancy: Diagnosis and Management. 2019. Accessed June 15, 2026. https://www.nice.org.uk/guidance/ng133
  35. Клинические рекомендации. Преэклампсия. Эклампсия. Отеки, протеинурия и гипертензивные расстройства во время беременности, в родах и послеродовом периоде. 2024. Одобрено Научно-практическим Советом Минздрава РФ. Ссылка активна на 25.06.26. https://diseases.medelement.com/disease/%D0%BF%D1%80%D0%B5%D1%8D%D0%BA%D0%BB%D0%B0%D0%BC%D0%BF%D1%81%D0%B8%D1%8F-%D1%8D%D0%BA%D0%BB%D0%B0%D0%BC%D0%BF%D1%81%D0%B8%D1%8F-%D0%BE%D1%82%D0%B5%D0%BA%D0%B8-%D0%BF%D1%80%D0%BE%D1%82%D0%B5%D0%B8%D0%BD%D1%83%D1%80%D0%B8%D1%8F-%D0%B8-%D0%B3%D0%B8%D0%BF%D0%B5%D1%80%D1%82%D0%B5%D0%BD%D0%B7%D0%B8%D0%B2%D0%BD%D1%8B%D0%B5-%D1%80%D0%B0%D1%81%D1%81%D1%82%D1%80%D0%BE%D0%B9%D1%81%D1%82%D0%B2%D0%B0-%D0%B2%D0%BE-%D0%B2%D1%80%D0%B5%D0%BC%D1%8F-%D0%B1%D0%B5%D1%80%D0%B5%D0%BC%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D0%B8-%D0%B2-%D1%80%D0%BE%D0%B4%D0%B0%D1%85-%D0%B8-%D0%BF%D0%BE%D1%81%D0%BB%D0%B5%D1%80%D0%BE%D0%B4%D0%BE%D0%B2%D0%BE%D0%BC-%D0%BF%D0%B5%D1%80%D0%B8%D0%BE%D0%B4%D0%B5-%D0%BA%D1%80-%D1%80%D1%84-2024/18178
  36. Witkowski P, Dzieński B, Stefańska K, Tomaszewicz M, Zabielska-Kaczorowska M, Wydra D. Preeclampsia: Contemporary Concepts in Pathophysiology, Risk Stratification, Prevention and Monitoring. Journal of Clinical Medicine. 2026;15(5):1944. https://doi.org/10.3390/jcm15051944
  37. Roberts JM, Rich-Edwards JW, McElrath TF, Garmire L, Myatt L; Global Pregnancy Collaboration. Subtypes of Preeclampsia: Recognition and Determining Clinical Usefulness. Hypertension. 2021 May 5;77(5):1430-1441. https://doi.org/10.1161/HYPERTENSIONAHA.120.14781
  38. Myatt L. The prediction of preeclampsia: the way forward. American Journal of Obstetrics and Gynecology. 2022;226(2S):S1102-S1107.e8. https://doi.org/10.1016/j.ajog.2020.10.047
  39. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 125: Chronic hypertension in pregnancy. Obstetrics and Gynecology. 2012;119(2 Pt 1):396-407. https://doi.org/10.1097/AOG.0b013e318249ff06
  40. Rybak-Krzyszkowska M, Staniczek J, Kondracka A, Bogusławska J, Kwiatkowski S, Góra T, Strus M, Górczewski W. From Biomarkers to the Molecular Mechanism of Preeclampsia-A Comprehensive Literature Review. International Journal of Molecular Sciences. 2023 Aug 26;24(17):13252. https://doi.org/10.3390/ijms241713252
  41. Redman CWG, Staff AC, Roberts JM. Syncytiotrophoblast stress in preeclampsia: the convergence point for multiple pathways. American Journal of Obstetrics and Gynecology. 2022;226(2S):S907-S927. https://doi.org/10.1016/j.ajog.2020.09.047
  42. Hernandez-Diaz S, Toh S, Cnattingius S. Risk of preeclampsia in first and subsequent pregnancies: Prospective cohort study. BMJ. 2009;338:b2255.
  43. Kariori M, Katsi V, Tsioufis C. Late vs. Early Preeclampsia. International Journal of Molecular Sciences. 2025 Nov 16;26(22):11091. https://doi.org/10.3390/ijms262211091
  44. Espino-Y-Sosa S, Moreno-Verduzco ER, Monroy-Muñoz IE, Solis-Paredes JM, Pérez Durán J, Rojas Zepeda L, Torres-Torres J. Rethinking Risk Prediction in Preeclampsia: From Biomarkers to Mechanistic Phenotypes and Longitudinal Models. International Journal of Molecular Sciences. 2026 Apr 13;27(8):3480. https://doi.org/10.3390/ijms27083480
  45. Sá CPN, Jiménez MF, Rosa MW, Arlindo EM, Ayub ACK, Cardoso RB, Kreitchmann R, El Beitune P. Evaluation of Angiogenic Factors (PlGF and sFlt-1) in Pre-eclampsia Diagnosis. Revista brasileira de ginecologia e obstetricia. 2020 Nov;42(11):697-704. https://doi.org/10.1055/s-0040-1713916
  46. Magee LA, Nicolaides KH, Von Dadelszen P. Preeclampsia. The New England journal of medicine. 2022;386:1817-1832. https://doi.org/10.1056/NEJMra2109523
  47. Fishel Bartal M, Sibai BM. Eclampsia in the 21st century. American Journal of Obstetrics and Gynecology. 2022 Feb;226(2S):S1237-S1253. https://doi.org/10.1016/j.ajog.2020.09.037
  48. Laskowska M, Bednarek A and Stworowski M. The Etiopathogenesis of Preeclampsia: Where Do We Stand Now? Journal of Clinical Medicine. 2025;14:7992. https://doi.org/10.3390/jcm14227992
  49. Lourenço J, Guedes-Martins L. Pathophysiology of Maternal Obesity and Hypertension in Pregnancy. Journal of Cardiovascular Development and Disease. 2025 Mar 3;12(3):91. https://doi.org/10.3390/jcdd12030091
  50. Masini G, Foo, LF, Tay J, Wilkinson IB, Valensise H, Gyselaers W, Lees CC. PE has two phenotypes which require different treatment strategies. American Journal of Obstetrics and Gynecology. 2022; 226 (Suppl. S2):S1006-S1018. https://doi.org/10.1016/j.ajog.2020.10.052
  51. Vu V-D, Chu Q-C, Nguyen P-T, Do T-T, Dang V-T, Nguyen V-A, Mai T-H, Nguyen T-H and Dang V-S. Development and internal validation of the LATE-PE model for predicting time-to-delivery in early-onset preeclampsia: a multicenter study. Frontiers of Medicine. 2026;13:1870604. https://doi.org/10.3389/fmed.2026.1870604
  52. Schwartz KS, Stanhewicz AE. Maternal Microvascular Dysfunction During and After Preeclamptic Pregnancy. Comprehensive Physiology. 2024 Oct 9;14(4):5703-5727. https://doi.org/10.1002/cphy.c240003
  53. Melchiorre K, Giorgione V, Thilaganathan B. The placenta and preeclampsia: villain or victim? American Journal of Obstetrics and Gynecology. 2022 Feb;226(2S):S954-S962. https://doi.org/10.1016/j.ajog.2020.10.024
  54. Chaiworapongsa T, Romero R, Gotsch F, Suksai M, Gallo DM, Jung E, Krieger A, Chaemsaithong P, Erez O, Tarca AL. Preeclampsia at term can be classified into 2 clusters with different clinical characteristics and outcomes based on angiogenic biomarkers in maternal blood. American Journal of Obstetrics and Gynecology. 2023 May;228(5):569.e1-569.e24. https://doi.org/10.1016/j.ajog.2022.11.001
  55. Riano-Moreno JC, Vargas-Castellanos E, Pedraza A, Díaz-Quiñonez LS, Rangel-Ramos VS. Preeclampsia prediction and diagnosis: a comprehensive historical review from clinical insights to omics perspectives. Frontiers in Medicine. 2025;12:1689745. https://doi.org/10.3389/fmed.2025.1689745
  56. Brodowski L, Knoth M, Zehner L, Pecks U. Assessing Severity and Need for Delivery in Early Onset Preeclampsia Before 32 Weeks of Gestation: a Delphi Consensus Procedure. Geburtshilfe Frauenheilkd. 2024 Aug 6;84(8):760-772. https://doi.org/10.1055/a-2361-0563
  57. Ohseto H, Ishikuro M, Shinoda G, Noda A, Murakami K, Orui M, Iwama N, Kikuya M, Metoki H, Hozawa A, Obara T, Kuriyama Sh. The relationship between preeclampsia subtypes and birth weight to placental weight ratio: insights from a study of 17709 pregnant Japanese women. Placenta. 2025;172:100-103. https://doi.org/10.1016/j.placenta.2025.10.017
  58. Huppertz B. An updated view on the origin and use of angiogenic biomarkers for preeclampsia. Expert Review of Molecular Diagnostics. 2018;18:1053-1061. https://doi.org/10.1080/14737159.2018.1546579
  59. Staff AC, Fjeldstad HE, Fosheim IK, Moe K, Turowski G, Johnsen GM, Alnaes-Katjavivi P, Sugulle M. Failure of physiological transformation and spiral artery atherosis: their roles in preeclampsia. American Journal of Obstetrics and Gynecology. 2022 Feb;226(2S):S895-S906. https://doi.org/10.1016/j.ajog.2020.09.026
  60. Hong K, Kim SH, Cha DH, Park HJ. Defective Uteroplacental Vascular Remodeling in Preeclampsia: Key Molecular Factors Leading to Long Term Cardiovascular Disease. International Journal of Molecular Sciences. 2021 Oct 18;22(20):11202. https://doi.org/10.3390/ijms222011202
  61. Gusella A, Martignoni G, Giacometti C. Behind the Curtain of Abnormal Placentation in Pre-Eclampsia: From Molecular Mechanisms to Histological Hallmarks. International Journal of Molecular Sciences. 2024;25(14):7886. https://doi.org/10.3390/ijms25147886
  62. Yagel S, Cohen SM, Goldman-Wohl D. An integrated model of preeclampsia: a multifaceted syndrome of the maternal cardiovascular-placental-fetal array. American Journal of Obstetrics and Gynecology. 2022 Feb;226(2S):S963-S972. https://doi.org/10.1016/j.ajog.2020.10.023
  63. Kornacki J, Olejniczak O, Sibiak R, Gutaj P, Wender-Ożegowska E. Pathophysiology of Pre-Eclampsia — Two Theories of the Development of the Disease. International Journal of Molecular Sciences. 2024; 25(1):307. https://doi.org/10.3390/ijms25010307
  64. Melchiorre K, Sharma R, Khalil A, Thilaganathan B. Maternal Cardiovascular Function in Normal Pregnancy: Evidence of Maladaptation to Chronic Volume Overload. Hypertension. 2016;67:754–762. https://doi.org/10.1161/HYPERTENSIONAHA.115.06667
  65. Lopez-Mendez MA, Martinez-Gaytan V, Cortes-Flores R, Ramos-Gonzalez RM, Ochoa-Torres MA, Garza-Veloz I, Martinez-Acuña MI, Badillo-Almaraz JI, Martinez-Fierro ML. Doppler ultrasound evaluation in preeclampsia. BMC Research Notes. 2013 Nov 19;6:477. https://doi.org/10.1186/1756-0500-6-477
  66. Chen Y, Huang M, Shi D, Lin J, Guo J, Yang Y, Li S, Lyu G. Correlation between fetal-placental doppler indices and maternal cardiac function in pregnant women with late-Onset preeclampsia or fetal growth restriction. BMC Pregnancy Childbirth. 2025 Jul 10;25(1):740. https://doi.org/10.1186/s12884-025-07848-x
  67. Wiles K, Chappell LC, Lightstone L, Bramham K. Updates in Diagnosis and Management of Preeclampsia in Women with CKD. Clinical Journal of the American Society of Nephrology. 2020 Sep 7;15(9):1371–1380. https://doi.org/10.2215/CJN.15121219
  68. Vincent KMM, Garner T, Stevens A, Cottrell EC, Myers JE, Higgins LE. Assessing Placental Dysfunction Subtypes in Pregnancies With a Low PlGF Centile. Hypertension. 2025 Jul;82(7):1249–1260. https://doi.org/10.1161/HYPERTENSIONAHA.124.24440
  69. Myatt L, Webster RP. Vascular biology of preeclampsia. Journal of Thrombosis and Haemostasis. 2009 Mar;7(3):375–84. https://doi.org/10.1111/j.1538-7836.2008.03259.x
  70. Akasaki Y. Angiogenic factors for early prediction of preeclampsia. Hypertension Research. 2024;47:2959–2960. https://doi.org/10.1038/s41440-024-01846-w
  71. Kim YN, Lee DS, Jeong DH, Sung MS, Kim KT. The relationship of the level of circulating antiangiogenic factors to the clinical manifestations of preeclampsia. Prenatal Diagnosis. 2009 May;29(5):464–70. https://doi.org/10.1002/pd.2203
  72. Vornic I, Buciu V, Furau CG, Gaje PN, Ceausu RA, Dumitru CS, Barb AC, Novacescu D, Cumpanas AA, Latcu SC, Cut TG, Zara F. Oxidative Stress and Placental Pathogenesis: A Contemporary Overview of Potential Biomarkers and Emerging Therapeutics. International Journal of Molecular Sciences. 2024 Nov 13;25(22):12195. https://doi.org/10.3390/ijms252212195
  73. Slobodchikova T, Tayzhanova D, Amirbekova Z, Vazenmiller D, Mustafin R, Izmailovich M. Genetic Variants in Preeclampsia During Pregnancy: A Hospital-Based Case–Control Study. Journal of Clinical Medicine. 2025, 14(11):3850. https://doi.org/10.3390/jcm14113850
  74. Nguyen-Thanh T, Nguyen-Vu PT, Le-Thi QA, Phan-Thi TN, Ha TM. Association between Maternal and Fetal Genetic Variants and Preeclampsia: Evidence from a Meta-Analysis. Current Issues in Molecular Biology. 2024 Aug 1;46(8):8282–8300. https://doi.org/10.3390/cimb46080489
  75. Huppertz B. Preeclampsia 2.0: limitations and challenges of the two-stage hypothesis, and beyond. Molecular Human Reproduction. 2026 Jan 7;32(1):gaag001. https://doi.org/10.1093/molehr/gaag001
  76. Дудникова А.В., Кончакова Е.А., Бедикян Э.А., Ершова Е.Р., Агутенков Р.В. Современные представления о механизмах развития преэклампсии. Журнал «Врач». 2024;35(1):40–43. https://doi.org/10.29296/25877305-2024-01-07
  77. Huppertz B. Placental pathology in pregnancy complications. Thrombosis Research. 2011 Feb;127 Suppl 3:S96–9. https://doi.org/10.1016/S0049-3848(11)70026-3
  78. Huppertz B. The Critical Role of Abnormal Trophoblast Development in the Etiology of Preeclampsia. Current Pharmaceutical Biotechnology. 2018;19(10):771–780. https://doi.org/10.2174/1389201019666180427110547
  79. Sugulle M, Fiskå BS, Jacobsen DP, Fjeldstad HE, Staff AC. Placental Senescence and the Two-Stage Model of Preeclampsia. American Journal of Reproductive Immunology. 2024;92(1):e13904. https://doi.org/10.1111/aji.13904
  80. Zamudio S, Borges M, Echalar L, Kovalenko O, Vargas E, Torricos T, Khan AA, Alvarez M, Illsley NP. Maternal and fetoplacental hypoxia do not alter circulating angiogenic growth effectors during human pregnancy. Biology of Reproduction. 2014 Feb 27;90(2):42. https://doi.org/10.1095/biolreprod.113.115592
  81. Chaiworapongsa T, Romero R, Gotsch F, Suksai M, Gallo DM, Jung E, Krieger A, Chaemsaithong P, Erez O, Tarca AL. Preeclampsia at term can be classified into 2 clusters with different clinical characteristics and outcomes based on angiogenic biomarkers in maternal blood. American Journal of Obstetrics and Gynecology. 2023 May;228(5):569.e1–569.e24. https://doi.org/10.1016/j.ajog.2022.11.001
  82. Chaiworapongsa T, Romero R, Gomez-Lopez N, Suksai M, Gallo DM, Jung E, Berry SM, Awonuga A, Tarca AL, Bryant DR. Preeclampsia at term: evidence of disease heterogeneity based on the profile of circulating cytokines and angiogenic factors. American Journal of Obstetrics and Gynecology. 2024 Apr;230(4):450.e1–450.e18. https://doi.org/10.1016/j.ajog.2023.10.002
  83. Vinayagam D, Leslie K, Khalil A, Thilaganathan B. Preeclampsia – What is to blame? The placenta, maternal cardiovascular system or both? World Journal of Obstetrics and Gynecology. 2015;4(4):77–85. https://doi.org/10.5317/wjog.v4.i4.77
  84. Ciepłucha A, Ropacka-Lesiak M, Sławek-Szmyt S, Szczepaniak-Chicheł L, Bartczak-Rutkowska A, Misan N, Tykarski A, Lesiak M, Kawka-Paciorkowska K. Maladaptation of the maternal cardiovascular system as a cause of fetal growth restriction: Study rationale and design. Kardiologia Polska. 2022;80(12):1263–1265. https://doi.org/10.33963/KP.a2022.0291
  85. Collins HE, Alexander BT, Care AS, Davenport MH, Davidge ST, Eghbali M, Giussani DA, Hoes MF, Julian CG, LaVoie HA, Olfert IM, Ozanne SE, Prewit EB, Warrington JP, Zhang L, Goulopoulou S. Guidelines for assessing maternal cardiovascular physiology during pregnancy and postpartum. American J ournal of Physiology. Heart and Circulatory Physiology. 2024;327:H191–H220. https://doi.org/10.1152/ajpheart.00055.2024.
  86. Patel D, Avesani M, Johnson MR, Di Salvo G, Savvidou MD. Maternal cardiovascular adaptation to pregnancy in obese pregnant women. Acta Obstetricia et Gynecologica Scandinavica. 2024;103:907–916. https://doi.org/10.1111/aogs.14777
  87. Minciuna DA, Haba MSC, Haba RM, Minciuna CD, Carauleanu A, Scripcariu IS, David C, Dimitriu DC, Socolov DG. Maternal Cardiovascular Phenotype in Fetal Growth Restriction with or Without Pre-Eclampsia: Insights from Echocardiography and Clinical Implications. Diagnostics (Basel). 2026 Jul 31;16(15):2414. https://doi.org/10.3390/diagnostics16152414
  88. Forst BJ, Chambliss LR, Majdalany DS. Cardiac Implications of Preeclampsia: A Review. Journal of Personalized Medicine. 2026;16:265. https://doi.org/10.3390/jpm16050265
  89. Thilaganathan B, Kalafat E. Cardiovascular System in Preeclampsia and Beyond. Hypertension. 2019 Mar;73(3):522–531. https://doi.org/10.1161/HYPERTENSIONAHA.118.11191
  90. Teperikidis L, Boulmpou A, Amin G, Polymenakos K, Tarlatzis B, Stone GW, Bhatt DL, Zoccai GB, Booz GW. Cardiac Remodeling in Preeclampsia: A Large Language Model-Assisted Meta-Analysis and Meta-Regression. Journal of Cardiovascular Pharmacology. 2026 Jun 1;87(6):403-419. https://doi.org/10.1097/FJC.0000000000001774
  91. Thilaganathan B. Maternal Cardiac Dysfunction Precedes Development of Preeclampsia. Hypertension. 2020 Aug;76(2):321-322. https://doi.org/10.1161/HYPERTENSIONAHA.120.15281
  92. Yang Y, Lewey J, Arany Z. Cardiovascular complications of pregnancy. Journal of Clinical Investigation. 2026 Jan 2;136(1):e198808. https://doi.org/10.1172/JCI198808
  93. Yerlikaya-Schatten G, Karner E, Heinzl F, Prausmüller S, Kastl S, Springer S and Zilberszac R. Cardiac function in pregnant women with preeclampsia. Frontiers in Cardiovascular Medicine. 2024;11:1415727. https://doi.org/10.3389/fcvm.2024.1415727
  94. Bergman K, Svanvik T, Basic C, Rosengren A, Zverkova Sandström T, Celind J, et al. Heart disease in pregnancy and risk of pre-eclampsia: a Swedish register-based study. Open Heart. 2024;11:e002728. https://doi.org/10.1136/openhrt-2024-002728
  95. Melchiorre K, Thilaganathan B. Maternal cardiac function in preeclampsia. Current Opinion in Obstetrics and Gynecology. 2011 Dec;23(6):440-447. https://doi.org/10.1097/GCO.0b013e32834cb7a4
  96. Dennehy N, Lees C. Preeclampsia: Maternal cardiovascular function and optimising outcomes. Early Human Development. 2022 Nov;174:105669. https://doi.org/10.1016/j.earlhumdev.2022.105669
  97. Gyselaers W. Preeclampsia Is a Syndrome with a Cascade of Pathophysiologic Events. Journal of Clinical Medicine. 2020 Jul 15;9(7):2245. https://doi.org/10.3390/jcm9072245
  98. Valensise H, Vasapollo B, Gagliardi G, Novelli GP. Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension. 2008 Nov;52(5):873-880. https://doi.org/10.1161/HYPERTENSIONAHA.108.117358
  99. Veena M Vernekar, Akshatha DS, Prashanth FG, Sreelatha S. Echocardiogram in Hypertensive Disorder and its Outcome. EC Gynaecology. 2022;11.6:39-47.
  100. Badenoosh B, Yazdani S, Hossieni Gohar S, Mehdizadeh Tourzani Z, Kabir K, Bakhtiyari M. Comparison of echocardiographic findings in women with late preeclampsia and healthy pregnant women: a case-control study. The Journal of Maternal–Fetal Neonatal Medicine. 2022 Dec;35(25):7491-7496. https://doi.org/10.1080/14767058.2021.1949707
  101. Gencheva D, Nikolov FP, Uchikova E, Mihaylov RD, Pencheva PG. Echocardiography and biomarker-based regression models for the detection of preeclampsia in pregnant women. European Heart Journal. October 2021;Volume 42, Issue Supplement_1:ehab724.2896. https://doi.org/10.1093/eurheartj/ehab724.2896
  102. Yerlikaya-Schatten G, Karner E, Heinzl F, Prausmüller S, Kastl S, Springer S, Zilberszac R. Cardiac function in pregnant women with preeclampsia. Frontiers in Cardiovascular Medicine. 2024 Dec 16;11:1415727. https://doi.org/10.3389/fcvm.2024.1415727
  103. Minciuna DA, Haba MSC, Haba RM, Minciuna CD, Carauleanu A, Scripcariu IS, David C, Dimitriu DC, Socolov DG. Maternal Cardiovascular Phenotype in Fetal Growth Restriction with or Without Pre-Eclampsia: Insights from Echocardiography and Clinical Implications. Diagnostics (Basel). 2026 Jul 31;16(15):2414. https://doi.org/10.3390/diagnostics16152414
  104. Shaw LJ, Patel K, Lala-Trindade A, Feltovich H, Vieira L, Kontorovich A, Ananth C, Taqueti VR, Mitrani L, Stern T, DeBolt C, Kase N, Smith RT, Narula J, Mehran R, Bianco A, Bhatt DL, Stone JL. Pathophysiology of Preeclampsia-Induced Vascular Dysfunction and Implications for Subclinical Myocardial Damage and Heart Failure. Journal of American Colledge Cardiology Advances. 2024 May 14;3(6):100980. https://doi.org/10.1016/j.jacadv.2024.100980
  105. Sławek-Szmyt S, Kawka-Paciorkowska K, Ciepłucha A, Lesiak M, Ropacka-Lesiak M. Preeclampsia and Fetal Growth Restriction as Risk Factors of Future Maternal Cardiovascular Disease — A Review. Journal of Clinical Medicine. 2022 Oct 13;11(20):6048. https://doi.org/10.3390/jcm11206048
  106. Palmiero P, Caretto P, Ciccone MM, Maiello M, On Behalf Of The I C I S C U Italian Chapter Of International Society Cardiovascular Ultrasound. Long-Term Cardiovascular Risk and Maternal History of Pre-Eclampsia. Journal of Clinical Medicine. 2025 Apr 30;14(9):3121. https://doi.org/10.3390/jcm14093121
  107. Inversetti A, Pivato CA, Cristodoro M, Latini AC, Condorelli G, Di Simone N, Stefanini G. Update on long-term cardiovascular risk after pre-eclampsia: a systematic review and meta-analysis. European Heart Journal — Quality of Care and Clinical Outcomes. 2024 Jan 12;10(1):4-13. https://doi.org/10.1093/ehjqcco/qcad065
  108. Ахмадеев Н.Р., Фаткуллин И.Ф., Фаткуллина Л.С. Сердечно-сосудистые последствия больших акушерских синдромов. Акушерство и гинекология. 2023;4:5-11. https://dx.doi.org/10.18565/aig.2022.287
  109. Shaw LJ, Patel K, Lala-Trindade A, Feltovich H, Vieira L, Kontorovich A, Ananth C, Taqueti VR, Mitrani L, Stern T, DeBolt C, Kase N, Smith RT, Narula J, Mehran R, Bianco A, Bhatt DL, Stone JL. Pathophysiology of Preeclampsia-Induced Vascular Dysfunction and Implications for Subclinical Myocardial Damage andHeart Failure. Journal of American Colledge Cardiology Advances. 2024 May 14;3(6):100980. https://doi.org/10.1016/j.jacadv.2024.100980
  110. Kutllovci Hasani K, Ajeti N, Goswami N. Understanding Preeclampsia: Cardiovascular Pathophysiology, Histopathological Insights and Molecular Biomarkers. Medical Sciences (Basel). 2025 Aug 25;13(3):154. https://doi.org/10.3390/medsci13030154
  111. Ridder A, Giorgione V, Khalil A, Thilaganathan B. Preeclampsia: The Relationship between Uterine Artery Blood Flow and Trophoblast Function. International Journal of Molecular Sciences. 2019 Jul 2;20(13):3263. https://doi.org/10.3390/ijms20133263
  112. Hu X, Zhang L. Uteroplacental Circulation in Normal Pregnancy and Preeclampsia: Functional Adaptation and Maladaptation. International Journal of Molecular Sciences. 2021;22(16):8622. https://doi.org/10.3390/ijms22168622
  113. Puspitasari MK, Siddiq A, Virgana R, Pramatirta AY, Irianti S, Handono B, Mose JC, Effendi JS. Hemodynamic Insights into Preeclampsia: Comparing Ophthalmic and Uterine Artery Resistive Indices. Medical Science Monitor. 2025 Jul 22;31:e947528. https://doi.org/10.12659/MSM.947528
  114. Kumari N, Ranjan RK, Rai N, Xalxo AR, Toppo SK, Ram PN. A Correlational Study of Ophthalmic Artery Doppler Parameters and Maternal Blood Pressure in Normotensive and Pre-eclamptic Pregnancies at a Tertiary Care Hospital. Cureus. 2023 Jun 20;15(6):e40713. https://doi.org/10.7759/cureus.40713
  115. Ranjkesh M, Khalafi M, Salehi V, Abdi S, Karbasi V, Gharepapagh E. Maternal Ophthalmic Artery Resistance in Pregnancies With Pre-Eclampsia Compared to Normotensive Participants. Australasian Journal of Ultrasound in Medicine. 2025;28(3):e70016. https://doi.org/10.1002/ajum.70016
  116. Procopciuc LM, Caracostea GV, Hangan AC, Lucaciu RL. Understanding Preeclampsia: Integrating Placental Dysfunction, Immune Dysregulation and microRNA-Mediated Epigenetic Regulation. International Journal of Molecular Sciences. 2026;27(10):4281. https://doi.org/10.3390/ijms27104281
  117. Thilaganathan B. Pre-eclampsia and the cardiovascular-placental axis. Ultrasound in Obstetrics and Gynecology. 2018 Jun;51(6):714-717. https://doi.org/10.1002/uog.19081
  118. Lopez-Jaramillo P, Barajas J, Rueda-Quijano SM, Lopez-Lopez C, Felix C. Obesity and Preeclampsia: Common Pathophysiological Mechanisms. Frontiers in Physiology. 2018 Dec 19;9:1838. https://doi.org/10.3389/fphys.2018.01838
  119. Giesen EM, Verlohren S, Blois SM. Multi-omic insights of preeclampsia and cardiovascular health outcomes. Communications Medicine. 2025 Oct 30;5(1):446. https://doi.org/10.1038/s43856-025-01165-2
  120. Mosca L, Benjamin EJ, Berra K, Bezanson J, Dolor RJ, Lloyd-Jones DM, Newby LK, Piña IL, Roger VL, Shaw LJ, Zhao D. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: A guideline from the American Heart Association. Circulation. 2011;123:1243-1262. https://doi.org/10.1161/CIR.0b013e31820faaf8
  121. Alsammani MA, Ahmed SR. Grand Multiparity: Risk Factors and Outcome in a Tertiary Hospital: a Comparative Study. Materia Socio-medica. 2015 Aug;27(4):244-247. https://doi.org/10.5455/msm.2015.27.244-247
  122. Filipec M, Jadanec Đurin M. Cardiovascular and Respiratory Adaptations During Pregnancy and Exercise in Pregnancy. Physiologia. 2025;5(3):30. https://doi.org/10.3390/physiologia5030030
  123. Collins HE, Alexander BT, Care AS, Davenport MH, Davidge ST, Eghbali M, Giussani DA, Hoes MF, Julian CG, LaVoie HA, Olfert IM, Ozanne SE, Bytautiene Prewit E, Warrington JP, Zhang L, Goulopoulou S. Guidelines for assessing maternal cardiovascular physiology during pregnancy and postpartum. American Journal of Physiology. Heart and Circulatory Physiology. 2024 Jul 1;327(1):H191-H220. https://doi.org/10.1152/ajpheart.00055.2024
  124. Yagel S, Cohen SM, Goldman-Wohl D, Beharier O. Redefining pre-eclampsia as Type I or II: implementing an integrated model of the maternal-cardiovascular-placental-fetal array. Ultrasound in Obstetrics and Gynecology. 2023 Mar;61(3):293-301. https://doi.org/10.1002/uog.26121
  125. Gamliel M, Goldman-Wohl D, Isaacson B, Gur C, Stein N, Yamin R, Berger M, Grunewald M, Keshet E, Rais Y, Bornstein C, David E, Jelinski A, Eisenberg I, Greenfield C, Ben-David A, Imbar T, Gilad R, Haimov-Kochman R, Mankuta D, Elami-Suzin M, Amit I, Hanna JH, Yagel S, Mandelboim O. Trained Memory of Human Uterine NK Cells Enhances Their Function in Subsequent Pregnancies. Immunity. 2018 May 15;48(5):951-962.e5. https://doi.org/10.1016/j.immuni.2018.03.030
  126. Bounds KR, Newell-Rogers MK, Mitchell BM. Four Pathways Involving Innate Immunity in the Pathogenesis of Preeclampsia. Frontiers in Cardiovascular Medicine. 2015 Apr 28;2:20. https://doi.org/10.3389/fcvm.2015.00020
  127. Geldenhuys J, Rossouw TM, Lombaard HA, Ehlers MM, Kock MM. Disruption in the Regulation of Immune Responses in the Placental Subtype of Preeclampsia. Frontiers in Immunology. 2018 Jul 20;9:1659. https://doi.org/10.3389/fimmu.2018.01659
  128. Deer E, Herrock O, Campbell N, Cornelius D, Fitzgerald S, Amaral LM, LaMarca B. The role of immune cells and mediators in preeclampsia. Nature Reviews Nephrology. 2023 Apr;19(4):257-270. https://doi.org/10.1038/s41581-022-00670-0
  129. Colucci F. The role of KIR and HLA interactions in pregnancy complications. Immunogenetics. 2017 Aug;69(8-9):557-565. https://doi.org/10.1007/s00251-017-1003-9
  130. Díaz-Peña R, de Los Santos MJ, Lucia A, Castro-Santos P. Understanding the role of killer cell immunoglobulin-like receptors in pregnancy complications. Journal of Assisted Reproduction and Genetics. 2019 May;36(5):827-835. https://doi.org/10.1007/s10815-019-01426-9
  131. Procopciuc LM, Caracostea GV, Hangan AC, Lucaciu RL. Understanding Preeclampsia: Integrating Placental Dysfunction, Immune Dysregulation and microRNA-Mediated Epigenetic Regulation. International Journal of Molecular Sciences. 2026;27(10):4281. https://doi.org/10.3390/ijms27104281
  132. Robillard PY, Hulsey TC, Alexander GR, Keenan A, de Caunes F, Papiernik E. Paternity patterns and risk of preeclampsia in the last pregnancy in multiparae. Journal of Reproductive Immunology. 1993 May;24(1):1-12. https://doi.org/10.1016/0165-0378(93)90032-d
  133. Kyrou D, Kolibianakis EM, Devroey P, Fatemi HM. Is the use of donor sperm associated with a higher incidence of preeclampsia in women who achieve pregnancy after intrauterine insemination? Fertility and Sterility. 2010 Mar 1;93(4):1124-1127. https://doi.org/10.1016/j.fertnstert.2008.12.021
  134. Di Mascio D, Saccone G, Bellussi F, Vitagliano A, Berghella V. Type of paternal sperm exposure before pregnancy and the risk of preeclampsia: A systematic review. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2020 Aug;251:246-253. https://doi.org/10.1016/j.ejogrb.2020.05.065
  135. Melchiorre K, Sutherland GR, Liberati M, Thilaganathan B. Preeclampsia is associated with persistent postpartum cardiovascular impairment. Hypertension. 2011 Oct;58(4):709-715. https://doi.org/10.1161/HYPERTENSIONAHA.111.176537
  136. Khorami-Sarvestani S, Vanaki N, Shojaeian S, Zarnani K, Stensballe A, Jeddi-Tehrani M, Zarnani A-H. Placenta: an old organ with new functions. Frontiers in Immunology. 2024;15:1385762. https://doi.org/10.3389/fimmu.2024.1385762
  137. Yagel S, Cohen SM, Goldman-Wohl D, Beharier O. Redefining pre-eclampsia as Type I or II: implementing an integrated model of the maternal-cardiovascular-placental-fetal array. Ultrasound in Obstetrics and Gynecology. 2023 Mar;61(3):293-301. https://doi.org/10.1002/uog.26121
  138. Krause M, De Vito G. Type 1 and Type 2 Diabetes Mellitus: Commonalities, Differences and the Importance of Exercise and Nutrition. Nutrients. 2023 Oct 7;15(19):4279. https://doi.org/10.3390/nu15194279
  139. Benschop L, Schalekamp-Timmermans S, Broere-Brown ZA, Roeters van Lennep JE, Jaddoe VWV, Roos-Hesselink JW, Ikram MK, Steegers EAP, Roberts JM, Gandley RE. Placental Growth Factor as an Indicator of Maternal Cardiovascular Risk After Pregnancy. Circulation. 2019 Apr 2;139(14):1698-1709. https://doi.org/10.1161/CIRCULATIONAHA.118.036632
slide-cover

Рекомендуем статьи по данной теме:

Иммуногистохимическая экспрессия миелопероксидазы, протеиназы 3 и нейтрофильной эластазы в плаценте при преэклампсии.Проблемы репродукции. 2026;32(5):100-106

Изменение состава и структуры белков субклеточных фракций плаценты при преэклампсии.Проблемы репродукции. 2026;32(4):109-114

Плацентарные нейротрофины — новые перспективные предикторы осложненного течения беременности и неблагоприятных перинатальных исходов.Российский вестник акушера-гинеколога. 2026;26(4):62-69

Нарушение ауторегуляции сетчатки и хориоидеи при преэклампсии.Вестник офтальмологии. 2026;142(3):110-119

Клинико-психопатологические аспекты аутоиммунных энцефалитов с антителами к NMDA-рецепторам и глутаматдекарбоксилазе в детском возрасте.Журнал неврологии и психиатрии им. С.С. Корсакова. 2026;126(6):7-16

Клиническое наблюдение тромбоцитопенической тромбоцитарной пурпуры во время беременности: алгоритм, дифференциальная диагностика, спасающая жизнь.Российский вестник акушера-гинеколога. 2026;26(2):58-63

Роль липополисахарида в развитии воспаления в плацентарной ткани при преэклампсии.Проблемы репродукции. 2026;32(2):97-103

Преэклампсия — нейрогенный конфликт матери и плода.Российский вестник акушера-гинеколога. 2026;26(1):63-70

Сравнительный анализ протеома плаценты в норме и при тяжелой преэклампсии.Российский вестник акушера-гинеколога. 2025;25(5):5-14

Влияние биопсии трофэктодермы на течение беременности и акушерские исходы.Проблемы репродукции. 2025;31(3):63-69

Издательство «Медиа Сфера»
РекламаДоставка/ОплатаО насКонтактыОбучение для редакцийПолитика конфиденциальностиПолитика обработки персональных данныхПубличная оферта на реализацию издательской продукции
ЖурналыПодпискаАрхивКнигиПроекты
  • RuStore

© 1998-2026

  • Телефоны издательства:

  • +7 (495) 482-41-18
  • +7 (495) 482-43-29
  • Прямой телефон отдела подписки
    (только по вопросам заказов и доставки журналов)

  • +7 (800) 250-18-12
  • пн-пт с 10:00 до 18:00

  • Telegram
  • VK
info@mediasphera.ru
  • Почтовый адрес:

  • Издательство «Медиа Сфера»,
    а/я 54, Москва, Россия, 127238

  • RuStore

© 1998-2026